Article ID Journal Published Year Pages File Type
8769185 Actas Urológicas Españolas 2017 9 Pages PDF
Abstract
In high-risk renal-cell carcinoma after nephrectomy, sunitinb has been considered as treatment choice. In localized prostate cancer, prostate-cancer-specific mortality was low irrespective of the treatment assigned (active monitoring, radical prostatectomy and external-beam radiotherapy). In metastatic castration-resistant prostate cancer new results of treatment with enzalutamide and abiraterone has been published, wich have been shown beneficial effects in metastatic and no metastatic patients.
Related Topics
Health Sciences Medicine and Dentistry Nephrology
Authors
, , , ,